Pediatric Sickle Cell Disease: A Potential Role for the Complement System
Daniel Diatlov(University of Toronto), Christoph Licht(University of Toronto), Melanie E. Jackson(Hospital for Sick Children), Walter H.A. Kahr(University of Toronto), Melanie Kirby‐Allen(University of Toronto), Melina Cheong(University of Toronto), Kevin H.M. Kuo(University Health Network), Arlette Bohorquez(Hospital for Sick Children)
Cited by 1
Related Papers
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
|Genetics in Medicine|2017|563
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
|Blood|2007|356
Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
|PLoS Genetics|2007|325
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320